UBS Backs Chart Industries (GTLS) as Merger Creates Diversified Flow Tech Powerhouse
Chart Industries Inc. (NYSE:GTLS) is one of the 10 most undervalued industrial stocks to buy according to analysts. On June 4, UBS analyst Manav Gupta maintained a Buy rating on Chart Industries today and set a price target of $225, implying a 40% potential upside.
The analyst's affirmation follows the announcement of the all-stock merger agreement between Chart Industries and Flowserve, which will form a new industrial player valued at around $19 billion. The deal is expected to close by the end of Q4 2025, pending shareholder and regulatory approvals.
A Control Valve Controlling the Flow of Gas from its Pipeline.
The merger brings together Flowserve's flow control capabilities and Chart's process technology expertise, forming a diversified business spanning energy, water, industrial gases, chemicals, and data centers. The combined company will have a presence in more than 50 countries.
The deal is expected to yield $300 million in cost synergies over the next three years and contribute to adjusted earnings per share (EPS) within the first year. The company will also maintain Flowserve's existing dividend policy.
A June 4 Bloomberg report noted that the two companies view the merger as a means to navigate demand cycles better and serve a broader customer base. However, the report points out that mergers of this size don't happen often, mainly because they can be difficult to pull off, whether due to cultural differences, challenges in combining operations, or unclear strategic fit. The deal's success will depend largely on how well it's executed.
Chart Industries Inc. (NYSE:GTLS) is a global leader in the design, engineering, and manufacturing of process technologies and equipment used across the gas and liquid molecule supply chain. Its solutions support the production, storage, distribution, and end-use of atmospheric, hydrocarbon, and industrial gases, serving industries such as energy, industrial gas, and medical.
While we acknowledge the potential of GTLS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and .
Disclosure: None.
Errore nel recupero dei dati
Effettua l'accesso per consultare il tuo portafoglio
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
37 minutes ago
- Business Wire
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ('Hims & Hers' or 'the Company') (NYSE: HIMS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Hims & Hers is the subject of an announcement by Novo Nordisk issued on June 23, 2025. According to Novo Nordisk, it is ending its relationship with the Company 'due to concerns about their illegal mass compounding and deceptive marketing.' According to the press release, 'the FDA resolved the Wegovy ® shortage based on its conclusion that Novo Nordisk is fully meeting current and projected nationwide demand for this medicine. In support of transitioning patients from knock-off compounded versions to authentic, FDA-approved Wegovy ® through NovoCare ® Pharmacy, Novo Nordisk began collaborating with telehealth companies. Over one month into the collaboration, Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk.' Based on this news, shares of Hims & Hers fell by more than 32.4% in afternoon trading on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Bloomberg
37 minutes ago
- Bloomberg
Gold Falls as Haven Demand Ebbs After Trump Announces Ceasefire
Gold retreated as haven demand ebbed after US President Donald Trump announced that Israel and Iran had agreed to a ceasefire that would start about midnight Monday in Washington. Bullion fell as much as 0.6% to below $3,350 an ounce in early Asian trading. Trump, who made the surprise announcement on his Truth Social platform days after ordering airstrikes on Iran's nuclear facilities, said the accord is aimed at a lasting end to the fighting. There was no immediate comment from Iran or Israel.
Miami Herald
42 minutes ago
- Miami Herald
Veteran analyst who predicted stocks rally revamps forecast after US attack
The stock market has gone on a wild ride in 2025. After back-to-back years of 20% plus returns and the S&P 500 reaching all-time highs in February, a string of tariff announcements by President Donald Trump sent stocks tumbling nearly 20% through early April. The decline left many nervous that more losses were likely as investors updated valuation models to account for increased inflation and recession risk, and potentially lower corporate profits Don't miss the move: Subscribe to TheStreet's free daily newsletter However, instead of more losses, the market reversed, heading sharply higher. The S&P 500 gained almost 20% since April 9, when President Trump paused most of the reciprocal tariffs announced on April 2. The rally surprised many investors, but Fundstrat's Tom Lee wasn't among them. Lee has navigated the markets since the 1990s, correctly predicting the bear market bottom in 2023 and rally in 2024. More recently, he said in April that stocks would likely look past tariffs and head higher, an opinion that proved particularly prescient. Of course, stocks don't go up in a straight line, and things have gotten a little tougher recently. Israel's missile attacks on Iran, and Iran's response, increased oil prices last week and geopolitical risks ratcheted even higher when the US bombed three Iranian nuclear facilities over the weekend. Given the latest news, Lee revamped his outlook, offering up a new stock market Federal Reserve has had its work cut out for it over the past few years. In 2022, it launched the hawkish monetary policy since the 1980s after inflation spiked following Covid-era stimulus payments and zero interest rate policy. The rate hikes successfully muscled inflation to below 3% from over 8%, but inflation progress has stalled, and newly enacted tariffs have many expecting inflation will increase in the coming months. Related: Analyst unveils bold prediction as tariff deadline looms That possibility has boxed the Fed in. Unemployment has climbed to 4.2% from 3.4% in 2023, and normally, that increase would support interest rate cuts. However, with inflation already worrisome because of tariffs, the Fed has taken a wait-and-see approach this year, nervous that cuts would cause inflation to move up even more. The decision to keep rates at their current 4.25% to 4.5% level could backfire, pushing the Fed behind the curve, given the economy is also showing worrisome signs. In May, both the ISM Manufacturing and Services PMIs were below 50, signaling contraction. Furthermore, consumer confidence, while rebounding from its April low, is still troublesome. The Conference Board's Expectations Index was 72.8 in May, below the threshold of 80 that typically signals a recession ahead. The potential for the US economy to slow isn't lost on economists. The World Bank reduced its outlook for US GDP to 1.4% this year, down from 2.8% growth in 2024. The Fed similarly predicts 1.4% growth, down from 2.1% in December. Lee's long experience in the market means he's navigated the Internet boom and bust, the Great Financial Crisis, and the Covid-drop. His been-there-done-that background helped him predict that the bear market would end in 2022, setting the S&P 500 up to rally in 2023, and that stocks would continue to climb in 2024, even as many thought it would stall. Related: Fannie Mae chief Pulte sends savage one-word message to Fed's Powell While geopolitical risks in the Middle East increase uncertainty, Lee doesn't necessarily think that markets will decline as a result, and he wasn't surprised that the S&P 500 trended higher on Monday. "Markets were already kinda nervous and anxious and we already saw de-risking and the VIX was already elevated so I think in some ways this is probably pretty typical," said Lee in a CNBC interview. Often, stocks price in the hews beforehand, supporting the old Wall Street saying, "sell the rumor, buy the news." In this case, Lee cited a quip from long-time NYSE floor trader Art Cashin, "sell the buildup, buy the invasion" as to why he wasn't shocked that stocks moved up. More Experts Analyst makes bold call on stocks, bonds, and goldTheStreet Stocks & Markets Podcast #8: Common Sense Investing With David MillerVeteran fund manager sends dire message on stocks Lee wouldn't be surprised if stocks continued their winning ways, either. While he sees some speculative fervor building, including a return of SPAC listings and names like Circle Internet surging 74% over the past five days on passage of stablecoin legislation, he thinks the market isn't nearly as stretched as it was when speculation ran rampant in 2021. "There's actually a lot less risk taking by institutional investors," said Lee. "High net worth is not really that invested and institutions are still pretty cautious" Lee said that the macro backdrop isn't nearly as concerning as it could be, saying that there's more visibility on tariffs and "we have regulation and tax legislation visibility into 2026." He also noted that consumers expect inflation in the future to be much higher than it is today, providing plenty of opportunity for positive surprises. "With all the cash on the sidelines I would say we should be quite bullish, actually," concluded Lee. Related: Veteran fund manager sends dire message on stocks The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
